News ArchivesRead News
Implanted eye cells eased Parkinson’s
Thursday December 22, 2005
December 19, 2005(Reuters Health) - A handful of people with Parkinson’s disease showed marked improvement after surgeons implanted in their brains chemical-producing cells taken from the eye of a dead donor, researchers said last week.
Cells from the inner, or pigment, layer of the eye’s retina make levodopa, which Parkinson’s patients commonly take in pill form to replace lost production of the neurotransmitter dopamine.
Dopamine allows the brain to control the body’s movements.
For most patients, levodopa pills lose their effectiveness within five years, and larger and larger doses are needed to curb the involuntary movements and shaking symptomatic of the disease.
Many people on the drug develop involuntary writhing or dance-like movements.
The retina cells were cultivated and implanted in the brains of six patients with advanced Parkinson’s, researcher Natividad Stover of the University of Alabama said.
One year later, the patients scored 48 percent higher on tests of movement and coordination, and the improvement was sustained after two years, Stover wrote in the journal Archives of Neurology.
’’The implants were well tolerated," the report said. Improvement was also observed in daily living and quality of life.
Parkinson’s is a degenerative disease in which key brain cells that produce dopamine die off. Symptoms start with tremors and rigidity, and patients can end up paralyzed. The cause of the disease, which attacks 2 percent of men and 1.3 percent of women, is unknown, and there is no cure.
Some scientists have viewed implanting fetal stem cells into the brains of Parkinson’s patients as a promising avenue to restore dopamine production. But preliminary human trials were disappointing, and animal experiments have yielded mixed results.
Other treatments showing promise include deep brain stimulation with implanted electrodes, drugs that promote brain cell growth, and gene therapy.
The researchers said a larger study has been started to test the efficacy and safety of retina cell implants.
Recent NewsJun 22 - A Confused Immune System Could Be Behind Parkinson's Disease
Jun 21 - Predicting cognitive deficits in people with Parkinson’s disease
Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression